ASSESSMENT OF THE SAFETY OF ENDOBRONCHIAL VALVE USE IN PATIENTS WITH INFILTRATIVE PULMONARY TUBERCULOSIS IN THE PHASE OF DECAY
Abstract
The results of treatment using an endobronchial valve were analyzed in 49 patients with destructive infiltrative pulmonary tuberculosis. Endobronchial valve application caused complications in 14.3% of cases in the course of the underlying disease and the treatment policy was changed. Following endobronchial valve insertion, 40.8% of the patients were found to have clinical manifestations of the endobronchial valve being in the bronchus; all the symptoms were abolished with medications for 3 weeks. Endobronchial valve insertion induced granulation tissue growth in the area of bronchoblockation, followed by the development of varying cicatricial stenoses of the blocked bronchi. At the same time, the tuberculosis treatment could provide a clinical effect in 85.7% of the patients with infiltrative tuberculosis in the decay phase, with a history of treatment failures for 5 months or more.
About the Authors
S. V. Sklyuev
ФГБУ «Новосибирский научно-исследовательский институт туберкулеза» Минздрава России
Russian Federation
Russian Federation
A. V. Levin
ФГБУ «Новосибирский научно-исследовательский институт туберкулеза» Минздрава России
Russian Federation
Russian Federation
E. A. Tsemakh
ГБОУ ВПО «Алтайский государственный медицинский университет» Минздрава России
Russian Federation
г. Барнаул
Russian Federation
г. Барнаул
D. V. Krasnov
ФГБУ «Новосибирский научно-исследовательский институт туберкулеза» Минздрава России
Russian Federation
Russian Federation
E. P. Myshkova
ФГБУ «Новосибирский научно-исследовательский институт туберкулеза» Минздрава России
Russian Federation
Russian Federation
References
1. Краснов Д. В., Грищенко Н. Г., Бесчетный Т. Г. и др. Применение клапанной блокады бронха у больных распространенным фиброзно-кавернозным туберкулезом легких после остеопластической торакопластики // Туб. - 2010. - № 9. - С. 8-13.
2. Ловачева О. В., Шумская И. Ю., Туровцева Ю. В. и др. Новые возможности нехирургического лечения больных фиброзно-кавернозным туберкулезом легких // Туб. - 2013. - № 4. - С. 12-18.
3. Anile M. Treatment of persistent air leakage with end bronchial one-way valves // J. Thor. Cardiovasc. Surgery. - 2006. - Vol. 132, № 3. - P. 711-712.
4. de Oliveira H. et al. Transbronchoscopic pulmonary emphysema treatment: 1-month to 24-month endoscopic follow-up // Chest. - 2006. - Vol. 130, № 1. - P. 190-199.
5. Fann J. I., Berry G. J., Burdon T. A. The use of endobronchial valve device to eliminate air leak // Respir. Med. - 2006. - Vol. 100. - P. 1402-1406.
6. Ferguson J. S., Sprenger K., T. van Natta. Closure of a bronchopleural fistula using bronchoscopic placement of an end bronchial valve designed for the treatment of emphysema // Chest. - 2006. - Vol. 129, № 2. - P. 479-481.
7. Garzon J. C. et al. Video-assisted thoracic surgery lung resection after endobronchial valve placement // J. Thorac Cardiovasc Surg. - 2006. - Vol. 131. - P. 501-502.
8. Polkey M. I. Hopkinson, Bronchoscopic lung volume reduction // Eur. Respir. Rev. - 2006. - Vol. 15. - P. 99-103.
9. Toma T. P., Todrys K. W., Amon J. J. Reduction of persistent air leak with endoscopic valve implants // Thorax. - 2007. - Vol. 62, № 9. - P. 829-832.
10. Travaline J. M. Treatment of Persistent Pulmonary Air Leaks Using Endobronchial Valves // Chest. - 2009. - Pre-published online, April 6.
11. Tseimakh Ye., Levin A., Zimonin P. et al. Endobronchial valve in a complex treatment of a spontaneous pneumothorax // ERS Annual Congress. Barselona. - 2010. - P. 2768.
Review
For citations:
Sklyuev S.V., Levin A.V., Tsemakh E.A., Krasnov D.V., Myshkova E.P. ASSESSMENT OF THE SAFETY OF ENDOBRONCHIAL VALVE USE IN PATIENTS WITH INFILTRATIVE PULMONARY TUBERCULOSIS IN THE PHASE OF DECAY. Tuberculosis and Lung Diseases. 2014;(5):47-49. (In Russ.)
Views:
785
Email this article 